Thomas James E 的 Form 4/A 修正申報
修正Clarus Therapeutics Holdings, Inc.（CRXT），2022/4/25 申報
- 申報編號
- 0001062993-22-010736
- 申報時間
- 2022/4/25 17:17 ET
- 交易日
- 2022/4/20
- 申報延遲
- 5 天
- 10b5-1 計畫
- 表單沒有這欄（2023 年以前）
- 原始申報日
- 2022/4/21
這份申報列了 6 筆非衍生性交易。公開市場賣出合計 $949.5 萬。交易後 5 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Thomas James ECIK 0001204789 | 持股 10% 以上大股東 |
| TMP Associates LPCIK 0001226280 | 持股 10% 以上大股東 |
| Thomas McNerney & Partners LPCIK 0001231291 | 持股 10% 以上大股東 |
| Thomas, McNerney & Partners, LLCCIK 0001335196 | 持股 10% 以上大股東 |
| TMP Nominee, LLCCIK 0001335200 | 持股 10% 以上大股東 |
| Thomas, McNerney & Partners II L.P.CIK 0001369574 | 持股 10% 以上大股東 |
| TMP Associates II LPCIK 0001383035 | 持股 10% 以上大股東 |
| TMP Nominee II, LLCCIK 0001436054 | 持股 10% 以上大股東 |
| Thomas, McNerney & Partners II, LLCCIK 0001505930 | 持股 10% 以上大股東 |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2022/4/20 | Common Stock | S賣出處分 | −1,663,126 | $2.53F1 | −$4,207,708.78 | 773,599 | 間接 | |
| 2022/4/20 | Common Stock | S賣出處分 | −2,061,685 | $2.53F1 | −$5,216,063.05 | 958,989 | 間接 | |
| 2022/4/20 | Common Stock | S賣出處分 | −5,722 | $2.53F1 | −$14,476.66 | 2,661 | 間接 | |
| 2022/4/20 | Common Stock | S賣出處分 | −13,630 | $2.53F1 | −$34,483.9 | 6,340 | 間接 | |
| 2022/4/20 | Common Stock | S賣出處分 | −1,164 | $2.53F1 | −$2,944.92 | 542 | 間接 | |
| 2022/4/20 | Common Stock | S賣出處分 | −7,585 | $2.53F1 | −$19,190.05 | 3,528 | 間接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
The prices reported in this column are weighted average prices at a range of prices between $2.20 and $3.03. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges of the prices reported.
表 I 有 6 筆交易的價格引用這則附註。
- F2
The reported securities are held directly by Thomas, McNerney & Partners, L.P. ("TMP"). Thomas, McNerney & Partners, LLC ("TMP LLC") is the general partner of TMP and TMPA and has shared voting and dispositive power of the securities held by TMP and TMPA, but disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. James E. Thomas is the sole manager of TMP LLC. Each of the reporting persons disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities.
- F3
The reported securities are held directly by Thomas, McNerney & Partners II, L.P. ("TMP II"). Thomas, McNerney & Partners II, LLC ("TMP II LLC") is the general partner of TMP II and TMPA II and has shared voting and dispositive power of the securities held by TMP II and TMPA II, but disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. James E. Thomas is the sole manager of TMP II LLC. Each of the reporting persons disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities.
- F4
The reported securities are held directly by TMP Nominee, LLC ("TMPN"). James E. Thomas and Peter McNerney are the managers of TMPN and TMPN II and, as a result, may be deemed to have voting and dispositive power over the shares held by TMPN and TMPN II, respectively, provided that they are obligated to exercise such power in the same manner as TMP LLC and TMP II LLC vote and dispose of the securities of the Issuer over which TMP LLC and TMP II LLC exercise voting and dispositive power, respectively. James E. Thomas is the sole manager of TMP LLC and TMP II LLC. Each of the reporting persons disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities.
- F5
The reported securities are held directly by TMP Nominee II, LLC ("TMPN II"). James E. Thomas and Peter McNerney are the managers of TMPN and TMPN II and, as a result, may be deemed to have voting and dispositive power over the shares held by TMPN and TMPN II, respectively, provided that they are obligated to exercise such power in the same manner as TMP LLC and TMP II LLC vote and dispose of the securities of the Issuer over which TMP LLC and TMP II LLC exercise voting and dispositive power, respectively. James E. Thomas is the sole manager of TMP LLC and TMP II LLC. Each of the reporting persons disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities.
- F6
The reported securities are held directly by TMP Associates, L.P. ("TMPA"). TMP LLC is the general partner of TMP and TMPA and has shared voting and dispositive power of the securities held by TMP and TMPA, but disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. James E. Thomas is the sole manager of TMP LLC. Each of the reporting persons disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities.
- F7
The reported securities are held directly by TMP Associates II, L.P. ("TMPA II"). TMP II LLC is the general partner of TMP II and TMPA II and has shared voting and dispositive power of the securities held by TMP II and TMPA II, but disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein. James E. Thomas is the sole manager of TMP II LLC. Each of the reporting persons disclaims beneficial ownership of the reported securities except to the extent of such person's or entity's pecuniary interest in such securities.
備註
This Form 4 was previously filed under the incorrect CIK (for Clarus Therapeutics Inc.) and is being refiled under the correct CIK.